1887

Abstract

Transcription of oncogenes E6 and E7 of human papillomavirus type 16 (HPV-16) from the P97 promoter is regulated by viral and cellular proteins. The transcription factor YY1 represses transcription through binding to cognate sequences in the long control region (LCR). In HPV-16 DNA from cervical carcinomas, mutations of YY1-binding sites have been identified that increase P97 activity 3–6-fold. A second, SP1-binding site has now been identified in the HPV-16 LCR (nt 7842–7847), which overlaps the YY1-binding site at positions 7840–7848. A point mutation within this YY1 site in viral DNA from a cervical cancer, previously shown to prevent YY1 binding, was shown to increase SP1 binding and P97 activity 4·7-fold. An engineered mutant eliminating SP1 binding showed only 1- to 1·6-fold increased P97 activity. It is concluded that competition between SP1 and YY1 for DNA binding plays a major role in YY1 repression mediated by the binding site at positions 7840–7848.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-8-2097
1999-08-01
2020-10-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/8/0802097a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-8-2097&mimeType=html&fmt=ahah

References

  1. Apt D., Chong T., Liu Y., Bernard H. U.. 1993; Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. Journal of Virology67:4455–4463
    [Google Scholar]
  2. Apt D., Watts R. M., Suske G., Bernard H. U.. 1996; High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology224:281–291
    [Google Scholar]
  3. Chan W. K., Klock G., Bernard H. U.. 1989; Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. Journal of Virology63:3261–3269
    [Google Scholar]
  4. Chan W. K., Chong T., Bernard H. U., Klock G.. 1990; Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promoters through AP1 binding sites. Nucleic Acids Research18:763–769
    [Google Scholar]
  5. Dong X.-P., Stubenrauch F., Beyer-Finkler E., Pfister H.. 1994; Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. International Journal of Cancer58:803–808
    [Google Scholar]
  6. Gloss B., Bernard H. U.. 1990; The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. Journal of Virology64:5577–5584
    [Google Scholar]
  7. Inouye C. J., Seto E.. 1994; Relief of YY1-induced transcriptional repression by protein–protein interaction with the nucleolar phosphoprotein B23. Journal of Biological Chemistry269:6506–6510
    [Google Scholar]
  8. Ishiji T., Lace M. J., Parkkinen S., Anderson R. D., Haugen T. H., Cripe T. P., Xiao J.-H., Davidson I., Chambon P., Turek L. P.. 1992; Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO Journal11:2271–2281
    [Google Scholar]
  9. Kadonaga J. T., James K. A., Tjian R.. 1986; Promoter activation of RNA polymerase II transcription by Sp1. Trends in Biochemical Sciences11:20–23
    [Google Scholar]
  10. Klug J., Beato M.. 1996; Binding of YY1 to a site overlapping a weak TATA box is essential for transcription from the uteroglobin promoter in endometrial cells. Molecular and Cellular Biology16:6398–6407
    [Google Scholar]
  11. Kyo S., Inoue M., Nishio Y., Nakanishi K., Akira S., Inoue S., Yutsudo M., Tanizawa O., Hakura A.. 1993; NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region. Journal of Virology67:1058–1066
    [Google Scholar]
  12. Lee T. C., Shi Y., Schwartz R. J.. 1992; Displacement of BrdUrd-induced YY1 by serum response factor activates skeletal α-actin transcription in embryonic myoblasts. Proceedings of the National Academy of Sciences USA89:9814–9818
    [Google Scholar]
  13. Lee J. S., See R. H., Galvin K. M., Wang J., Shi Y.. 1995; Functional interactions between YY1 and adenovirus E1A. Nucleic Acids Research23:925–931
    [Google Scholar]
  14. Lu S. Y., Rodriguez M., Liao W. S.. 1994; YY1 represses rat serum amyloid A1 gene transcription and is antagonized by NF-κB during acute-phase response. Molecular and Cellular Biology14:6253–6263
    [Google Scholar]
  15. May M., Dong X.-P., Beyer-Finkler E., Stubenrauch F., Fuchs P. G., Pfister H.. 1994; The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO Journal13:1460–1466
    [Google Scholar]
  16. Natesan S., Gilman M. Z.. 1993; DNA bending and orientation-dependent function of YY1 in the c-fos promoter. Genes & Development7:2497–2509
    [Google Scholar]
  17. Natesan S., Gilman M.. 1995; YY1 facilitates the association of serum response factor with the c-fos serum response element. Molecular and Cellular Biology15:5975–5982
    [Google Scholar]
  18. O’Connor M., Bernard H.-U.. 1995; Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology207:77–88
    [Google Scholar]
  19. O’Connor M. J., Tan S. H., Tan C. H., Bernard H. U.. 1996; YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. Journal of Virology70:6529–6539
    [Google Scholar]
  20. Pazin M. J., Kadonaga J. T.. 1997; What’s up and down with histone deacetylation and transcription?. Cell89:325–328
    [Google Scholar]
  21. Rose B., Steger G., Dong X.-P., Thompson C., Cossart Y., Tattersall M., Pfister H.. 1998; Point mutations in Sp1 motifs in the upstream regulatory region of human papillomavirus type 18 isolates from cervical cancers increase promoter activity. Journal of General Virology79:1659–1663
    [Google Scholar]
  22. Shi Y., Seto E., Chang L.-S., Shenk T.. 1991; Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein. Cell67:377–388
    [Google Scholar]
  23. Shrivastava A., Saleque S., Kalpana G. V., Artandi S., Goff S. P., Calame K.. 1993; Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science262:1889–1892
    [Google Scholar]
  24. Sibbet G. J., Cuthill S., Campo M. S.. 1995; The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1. Journal of Virology69:4006–4011
    [Google Scholar]
  25. Su W., Jackson S., Tjian R., Echols H.. 1991; DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1. Genes & Development5:820–826
    [Google Scholar]
  26. Yang W.-M., Inouye C., Zeng Y., Bearss D., Seto E.. 1996; Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proceedings of the National Academy of Sciences USA93:12845–12850
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-8-2097
Loading
/content/journal/jgv/10.1099/0022-1317-80-8-2097
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error